Miach Orthopaedics specializes in innovative solutions for anterior cruciate ligament (ACL) injuries, prominently featuring the BEAR® Implant. This technology is designed to facilitate the healing of torn ACLs by utilizing the patient's own blood. The BEAR Implant is strategically inserted between the torn ends of the ACL, promoting natural healing and ultimately being replaced by the body’s own regenerated tissue. This approach not only aims to restore the functionality of the knee but also enhances the overall recovery process for patients suffering from ACL injuries.

In addition to the BEAR Implant, Miach Orthopaedics is actively involved in clinical studies to further validate and improve their technologies. The company emphasizes the importance of clinical evidence and provides resources for healthcare professionals to understand the mechanics and benefits of the BEAR Implant. By fostering a community of patients and healthcare providers, Miach Orthopaedics aims to inspire and support individuals on their journey to recovery from ACL injuries.

United States

Developer of bio-engineered surgical implants designed to facilitate new tissue growth and also aid in connective tissue repair. The company's implants specialize in viable alternatives to conventional ACL reconstruction for patients who have sustained any kind of leg injury, enabling surgeons to perform surgery to restore normal anatomy and function of the knee.

Miach Orthopaedics

Company Details